Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
Clinical trial NCT00383214 · TERMINATED
Trial details
- NCT number
- NCT00383214
- Sponsor
- UCB Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2007-03-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.